跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

AI Antibody Design vs Human Design: A Conceptual Overview

1Why Antibody Design Matters2How Humans Design Antibodies3How AI Learns to Design Antibodies4Comparing AI and Human Design5Evidence, Limits, and Open Questions
How Humans Design Antibodies

Four Routes to a Candidate Antibody

1 / 4
Notice the shape of this diagram. Three arrows start from different places — one from an immunized animal, one from a large displayed library, one from a known structure — and all three land on the same box: a candidate antibody sequence. That convergence is the point. The routes differ in where the diversity comes from, not in what they deliver. Then look at the loop drawn around the candidate. Affinity maturation is not a fourth starting point; it is what you do after you already have something that binds, and you can apply it to a candidate that came from any of the three arrows.
0:00 / 0:00

Human scientists reach a target-binding antibody by four broad routes, and they are usually combined rather than used in isolation.

Immunization and hybridoma discovery uses biology as the search engine. An animal is immunized with the target antigen; its immune system generates and selects B cells whose antibodies bind that antigen. The scientist then fuses a B cell with a myeloma cell to create a hybridoma — an immortal cell line that keeps secreting the same antibody. The output is a monoclonal antibody with a known, reproducible sequence.

Display-based selection builds the diversity artificially. A large library of antibody variants is displayed on the surface of phage particles, each particle carrying the gene for the variant it displays. The library is exposed to immobilized target; non-binders are washed away; bound variants are recovered and re-amplified. Because the variant and its gene travel together, a recovered binder can be identified and produced.

Rational, structure-guided engineering starts from knowledge rather than from a library. If the structure of the antibody–antigen interface is known or can be modeled, the scientist can identify which residues contact the antigen and change them deliberately.

Affinity maturation is not a separate starting point but a loop applied to candidates from any of the other routes: mutate the binding region, express the variants, measure binding, and keep the best.

All four routes converge on the same deliverable — a defined antibody sequence that binds the chosen target — and all four are steered by human decisions about target, format, and acceptance criteria.

参考资料

  1. [1]Phage display — Nobel Prize popular informationnobelprize.org
上一页1 / 4下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion